HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Wakako Maruyama Selected Research

rasagiline (Azilect)

1/2013''70th Birthday Professor Riederer'' induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy?
4/2012Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
1/2010Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.
8/2009Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.
6/2005Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline.
1/2005Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition.
5/2004N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor.
5/2003Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor.
8/2002Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan.
6/2002An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Wakako Maruyama Research Topics

Disease

22Parkinson Disease (Parkinson's Disease)
06/2013 - 06/2002
11Neurodegenerative Diseases (Neurodegenerative Disease)
03/2013 - 05/2004
9Neuroblastoma
12/2008 - 03/2002
2Anoxia (Hypoxia)
06/2005 - 01/2005
2Craniocerebral Trauma (Head Injury)
06/2005 - 01/2005
2Ischemia
06/2005 - 01/2005
2Mitochondrial Diseases (Mitochondrial Disease)
01/2005 - 01/2002
1Renal Insufficiency (Renal Failure)
02/2010
1Kidney Diseases (Kidney Disease)
02/2010
1Inflammation
01/2010
1Alzheimer Disease (Alzheimer's Disease)
01/2005
1Lewy Body Disease (Lewy Body Dementia)
05/2003
1Ataxia (Dyssynergia)
01/2002
1Leigh Disease (Leigh's Disease)
01/2002
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2002
1Muscle Weakness
01/2002

Drug/Important Bio-Agent (IBA)

12Dopamine (Intropin)FDA LinkGeneric
06/2013 - 03/2002
11Monoamine Oxidase (MAO)IBA
03/2013 - 01/2005
10rasagiline (Azilect)FDA Link
01/2013 - 06/2002
5NeurotoxinsIBA
03/2013 - 01/2005
5salsolineIBA
05/2004 - 08/2002
4Selegiline (E250)FDA LinkGeneric
01/2013 - 08/2009
3Nerve Growth Factors (Neurotrophins)IBA
04/2012 - 08/2009
3NitrogenIBA
02/2010 - 11/2003
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2013 - 05/2004
2Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
01/2013 - 01/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2012 - 01/2011
2Neuroprotective AgentsIBA
01/2010 - 05/2004
2neuromelaninIBA
11/2009 - 06/2008
2Levodopa (L Dopa)FDA LinkGeneric
06/2005 - 01/2005
2Proteins (Proteins, Gene)IBA
01/2005 - 11/2003
2OxygenIBA
01/2005 - 11/2003
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2011
1Parathyroid Hormone (Parathormone)IBA
02/2010
1CreatinineIBA
02/2010
1Collagen Type I (Type I Collagen)IBA
02/2010
11,25-dihydroxyvitamin DIBA
02/2010
1Urea (Carbamide)FDA LinkGeneric
02/2010
1collagen type I trimeric cross-linked peptideIBA
02/2010
1AdenineFDA LinkGeneric
02/2010
1CalciumIBA
02/2010
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2010
1Arachidonic Acid (Vitamin F)IBA
12/2008
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2008
1Biogenic Amines (Biogenic Amine)IBA
01/2005
1Caspase 8 (Caspase-8)IBA
09/2004
1Caspase 3 (Caspase-3)IBA
09/2004
1LigninIBA
09/2004
1Caspase 9IBA
09/2004
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2004
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2004
1Messenger RNA (mRNA)IBA
05/2004
1NF-kappa B (NF-kB)IBA
05/2004
1Transcription Factors (Transcription Factor)IBA
05/2004
1N-propargylIBA
05/2004
1salsolinol N-methyltransferaseIBA
01/2004
1Acrolein (Aqualin)IBA
11/2003
1RotenoneIBA
11/2003
1Cholinesterases (Cholinesterase)IBA
05/2003
1Cytochromes b (Cytochrome b)IBA
11/2002
1salsolinolIBA
09/2002
1Cytochromes c (Cytochrome c)IBA
08/2002
1Oxidopamine (6 Hydroxydopamine)IBA
03/2002
1DNA Restriction Enzymes (Restriction Endonuclease)IBA
01/2002
1Protons (Proton)IBA
01/2002
1EnzymesIBA
01/2002